FBInvestor
Stocks / Aslan Pharmaceuticals Lt Adr
Institutional Ownership

Aslan Pharmaceuticals Lt Adr

CUSIP 04522R309COMASLNEURQ1 2026

No short-interest data on record yet

FINRA publishes consolidated short interest twice a month. Coverage expands as the bi-monthly feed runs.